Your browser doesn't support javascript.
loading
Wilson disease.
El-Youssef, Mounif.
Afiliación
  • El-Youssef M; Division of Gastroenterology and Hepatology and Internal Medicine, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minn. 55905, USA. el-youssef.mounif@mayo.edu
Mayo Clin Proc ; 78(9): 1126-36, 2003 Sep.
Article en En | MEDLINE | ID: mdl-12962167
Wilson disease is a rare disorder of copper metabolism that results in accumulation of copper in the liver and subsequently in other organs, mainly the central nervous system and the kidneys. Advances in the diagnosis and treatment of Wilson disease are discussed, with the emphasis that this is a disease of children, adolescents, and young adults. The myriad manifestations of Wilson disease make its diagnosis dependent on a high index of suspicion, and determination of its genetic background is helping to elucidate the genotype-phenotype correlation and the diversity of presentations. Treatment of Wilson disease has progressed from chelation therapy using D-penicillamine and trientine to the more recent use of zinc and finally to the establishment of liver transplantation as an urgent but excellent modality for fulminant presentation. The evolution of Wilson disease from a uniformly fatal disease to an eminently treatable disease during the past century is an example of the remarkable advances of modern medicine.
Asunto(s)
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Degeneración Hepatolenticular Límite: Humans Idioma: En Revista: Mayo Clin Proc Año: 2003 Tipo del documento: Article País de afiliación: Estados Unidos
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Degeneración Hepatolenticular Límite: Humans Idioma: En Revista: Mayo Clin Proc Año: 2003 Tipo del documento: Article País de afiliación: Estados Unidos